ANNUAL REPORT SCN 2007

Scandinavian Clinical Nutrition i Sverige AB (publ) releases the Annual Report for 2007.

From today onwards, the 2007 Annual Report of Scandinavian Clinical Nutrition AB is available on the company’s website www.scnutrition.com. A printed version can be ordered via mail (SCN AB, Strandvägen 7A, 114 56 Stockholm, Sweden), via phone +46 8 586 107 80, via fax +46 8 660 65 89, or via e-mail info@scnutrition.com.

The Annual General Meeting takes place in Stockholm on Thursday, May 22, 2008.

In comparison with the information presented in the unaudited Year-End and Q4 Report, reclassification of items in the Consolidated Cash Flow Statement and Change in Shareholders’ Equity have been made in the Annual Report.

For more information, please contact:

Ulf Söderberg, CEO, us@scnutrition.com, +46 708 13 22 81

Thomas Christensen, CFO, tc@scnutrition.com, +47 922 55 444

Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Coldizin, Immulina and Ledactin. Core competence and strategic alliances within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth on the international market. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).